The US O&E Director will be responsible for leading the generation and dissemination of robust and relevant O&E material that is aligned with the US Oncology Business and supports the value of oncology products in the US. The execution of this position will be conducted in close collaboration with US stakeholders, Regional Outcomes Researchers, functions within GH&V, and other cross-functional teams. In addition, this position will function with a One GH&V mindset and will work in a closely aligned fashion with Cross-Functional Leadership Team (CFLT) members to ensure there is a single and coordinated view on strategy and delivery for GH&V to the oncology business. This position resides within the GH&V O&E group, reporting to the US Oncology O&E Team Lead.
Watch: Career Advice
• Lead the development of US O&E strategy to support the value of oncology products in close partnership with the cross-functional matrix team.
• Lead the execution of US O&E studies and projects (including Non-Interventional Studies, registries, etc) in alignment with the US O&E strategy and demonstrate the value proposition of oncology products.
• Lead the timely development of pre- and post- launch deliverables including AMCP dossiers updates, adaptations of US Budget Impact or other economic models, and innovative tools to successfully support US launch and post-launch activities, including new indications.
• Develop strategic partnerships and research collaborations with key US key opinion leaders, Payers, IDNs, healthcare policy makers, and various academic and community oncology settings to support O&E strategies for oncology products.
• Proactively assess and strategically generate robust US Real World evidence that can be used promotionally with US Population based decision makers (Payers, IDNs, Pathway Organizations, etc.), and support successful reimbursement and appropriate patient access for the Oncology Business.
• Lead the development of appropriate data dissemination plans and communicate evidence generated via publications and conference presentations.
• Provide technical consultation in area of experience to other O&E scientists as needed.
• Participate in key cross-divisional task forces to help improve processes and standards in O&E research programs. Influence O&E policies and methodological advances inside and outside the company.
• Prepare clear, relevant and influential written reports and presentations for a variety of audiences and effectively present information to senior and executive management at Pfizer.
• Represent Pfizer before appropriate scientific, medical, regulatory, payer, patient & other meetings, as appropriate.
• Demonstrate effective change leadership and entrepreneurial thinker
• Serve as source of expertise/advice for others.
• Execute in a manner that is compliant, with integrity, and follows the appropriate SOPs and Engagement policies
Organizational Relationships
External
• Thought leaders in oncology and outcomes at key US payers and other organized customer segments (LGPs, ACOs, IDNs, etc.)
• Academic oncology and Outcomes Research thought leaders
• Leadership at outcomes research and policy vendors/consulting firms
• Leadership at key professional organizations such as NCCN, ISPOR, and ASCO
• Leadership at national level patient advocacy organizations
Internal
• Global and US Outcomes and Evidence
• Global Health & Value
• US Medical Affairs (HQ and Field based medical)
• US Medical Information
• US Commercial (Marketing, Payer Accounts, etc)
• Biostatistics
• Contracting and Operations
• Payer Channel and Access National and Regional account teams
• Policy
• Corporate Affairs
Qualifications
• Doctoral degree (PhD, DrPH, ScD) in health services research, public health, epidemiology, or health economics.
• Minimum 10 years of experience in health outcomes and related fields, 5 of which are as part of health economics and/or outcomes research teams in a pharmaceutical company.
• Strong working knowledge of the technical and methodological aspects of registries and observational study design and implementation. Capable of independently managing complex registry and non-interventional study projects.
• Strong methodological skills (study design, data analysis and interpretation) in cancer epidemiology or health services research is required
• Knowledge and experience in the Oncology therapeutic area.
• Experience with US Payers or Population Based Decision Makers is desirable.
• Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers
• Excellent oral and written English communication skills required
• Strong project management abilities (contracting, budgeting, vendor management) essential. Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities
• Ability to influence key members of medical and commercial teams constructively and without conflict.
• Skilled in functioning within a matrix organization where managing through influence is required.
• Exhibit strong collaboration skills and ability to engage across multiple functions and business units, manage consensus at various levels and cultivate strategic internal relationships across a highly matrixed organization.
• Organized and detail oriented with the ability to anticipate needs and to work proactively to prioritize & address/resolve
• Change oriented, comfortable responding to unexpected demands with tight timelines; team player.
Physical & Mental Requirements
• Demonstrated expert understanding of fundamental health services research methods (e.g., health economics, patient reported outcomes, study design, database analyses, epidemiology, statistics)
• Able to independently engage all levels of stakeholders in GH&V and the BU through strategic thinking, leading change, and building collaborative partnerships in a matrix environment
• Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities
Estimated Travel
Estimated 10-20% US based travel will be required.
Send To A Friend
Posts
